Extracorporeal CO2 Removal Devices Market Outlook, Leading Manufacturers, Industry Analysis And Forecast: Grand View Research Inc.

 Extracorporeal CO2 Removal Devices Market Growth & Trends

The global extracorporeal CO2 removal devices market size is estimated to reach USD 118.64 million by 2028, registering a CAGR of 5.27% over the forecast period, according to a new report by Grand View Research, Inc. Technological improvements have changed extracorporeal techniques for CO2 removal in a promising manner to avoid respiratory failure, worsening respiratory acidosis, and to possibly shorten or prevent the duration of invasive mechanical ventilation in patients with exacerbation of asthma and Chronic Obstructive Pulmonary Disease (COPD).

Extracorporeal CO2 removal devices are considered to be an efficient therapy for patients suffering from hypercapnia respiratory failure and may allow clinicians as well as healthcare professionals to improve lung-protective ventilation. These devices can remove adequate CO2 to allow a 50% reduction in alveolar minute ventilation resulting in a substantial reduction in PaCO2. Hence, various advantages associated with these devices are expected to augment the overall market growth.

Extracorporeal CO2 removal devices are effective, safe, and feasible. The usage of these tools in ventilation support has been suggested in clinical situations where they may be useful, including exacerbation of COPD and Acute Respiratory Distress Syndrome (ARDS). The increasing prevalence of COPD across the globe is predicted to accelerate market growth. According to the British Lung Association, around 1.2 million people are diagnosed with COPD in the U.K.

Several manufacturers in the market are focusing on developing technologically advanced and innovative devices to strengthen their industry position. For instance, in November 2015, Alung Technologies received an Expedited Access Pathway (EAP) from the FDA for its Hemolung Respiratory Assist System (RAS). In February 2016, Alung Technologies received USD 12 million financing from existing as well as new investors. This financing helped in the commercialization of Hemolung RAS.

Request a free sample copy or view report summary: Extracorporeal CO2 Removal Devices Market Report

Extracorporeal CO2 Removal Devices Market Report Highlights

• Extracorporeal CO2 machines held the largest revenue share of the global market in 2020 owing to the availability of a wide range of devices
• The COPD application segment accounted for a significant revenue share of the global market in 2020
• The venovenous access segment is expected to account for the largest share by 2028 due to advantages, such as decreased invasiveness, and potential for the early mobilization of patients
• The hospitals end-use segment is estimated to have the fastest CAGR over the forecast period due to the rising number of hospitals in developing economies and increasing competition in healthcare service providers
• North America held the largest market share in 2020 and is anticipated to maintain its dominance over the forecast period
• This is attributable to the growing prevalence of COPD & ARDS and the increasing adoption of advanced devices

Access Press Release@ https://www.grandviewresearch.com/press-release/global-extracorporeal-co2-removal-devices-market

Extracorporeal CO2 Removal Devices Market Segmentation

Grand View Research has segmented the global extracorporeal CO2 removal devices market on the basis of product, application, access, end use, and region:

Extracorporeal CO2 Removal Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Extracorporeal CO2 Machines
• Disposables
• Others

Extracorporeal CO2 Removal Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• ARDS
• COPD
• Bridge to Lung Transplant
• Others

Extracorporeal CO2 Removal Devices Access Outlook (Revenue, USD Million, 2016 - 2028)

• Venovenous
• Arteriovenous

Extracorporeal CO2 Removal Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Clinics
• Others

Extracorporeal CO2 Removal Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Extracorporeal CO2 Removal Devices Market

• Medtronic
• Getinge AB
• Xenios AG
• Alung Technologies
• ESTOR SpA
• Medica SpA
• Aferectica Srl

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Shingles Vaccine Market Overview, Analysis And Forecast To 2028: Grand View Research Inc.

 Shingles Vaccine Market Growth & Trends

The global shingles vaccine market size is expected to reach USD 6.35 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.9% from 2021 to 2028. Increasing incidence of shingles and high awareness regarding shingles in developed countries are contributing to the market growth. According to the CDC, nearly one million cases of shingles are reported each year in the United States. Furthermore, one out of three individuals in the country will develop the disease in their lifetime.

The increasing adoption of vaccines and an increase in the recommendation of vaccination by different government regulatory bodies are expected to drive the market over the forecast period. For instance, in February 2019, the U.K. Joint Committee of Vaccination and Immunization (JCVI) has recommended the use of the recombinant vaccine to prevent shingles in adults aged 60 to 70 years old.

The inclusion of shingles vaccines in national immunization programs of several countries is anticipated to propel the demand for vaccines. For instance, the shingles vaccine is a part of the national immunization program in the U.K. since 2013. The U.K. is the first country in the European region to introduce shingles vaccine in the national immunization program and it costs around USD 130 to the National Health Service (NHS) for each dose of the vaccine. Similarly, other countries such as the U.S., Italy, Australia, and some provinces of Canada and South Korea have also included the vaccine in their immunization program.

Besides, favorable initiatives undertaken by market players and regulatory bodies to increase the awareness among people who are at risk of developing the disease are expected to fuel the market growth over the coming years. For instance, GlaxoSmithKline plc. has launched a campaign to increase vaccination rates among older adults by educating people about the benefits associated with vaccination.

The high efficacy of vaccines is expected to increase the adoption over the forecast period. According to clinical trial results, Shingrix is highly efficient to prevent shingles and postherpetic neuralgia. Two doses of Shingrix are more than 90% effective to prevent the disease in adults aged 50 years and above. Protection stays above 85% for at least the first four years after getting vaccinated.

The availability of vaccines at lower prices, coupled with a high incidence of the disease and high vaccination rate in developed countries, is anticipated to fuel the market growth. The vaccination rate against shingles in the U.K., the U.S., France, Canada, Germany, and South Korea is higher compared to other countries owing to better reimbursement policies and high awareness levels regarding the disease and vaccines. For instance, the U.K. has the highest shingles vaccine uptake with more than 60% vaccination of eligible adults.

Request a free sample copy or view report summary: Shingles Vaccine Market Report

Shingles Vaccine Market Report Highlights

• By product, Shingrix held the largest share in 2020 owing to the high efficacy of the vaccine as compared to others. Shingrix is also expected to grow at a significant CAGR over the forecast period owing to the increasing recommendations by regulatory bodies to prevent shingles
• Based on vaccine type, the recombinant vaccine segment is anticipated to grow at a substantial rate over the forecast period due to the low risk associated with recombinant vaccines
• Asia Pacific is projected to witness the fastest growth during the forecast period owing to the high unmet needs and the rising adoption of vaccination programs in the region
• North America dominated the market in 2020 due to favorable reimbursement policies and rising initiatives to raise awareness among healthcare professionals and patients

Access Press Release@ https://www.grandviewresearch.com/press-release/global-shingles-vaccine-market

Shingles Vaccine Market Segmentation

Grand View Research has segmented the global shingles vaccine market on the basis of product, vaccine type, and region:

Shingles Vaccine Product Outlook (Revenue, USD Million, 2017 - 2028)

• Shingrix
• Zostavax
• SkyZoster

Shingles Vaccine Type Outlook (Revenue, USD Million, 2017 - 2028)

• Recombinant Vaccine
• Live Attenuated Vaccine

Shingles Vaccine Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Shingles Vaccine Market

• GlaxoSmithKline plc.
• SK chemicals
• Green Cross Corp
• CanSinoBIO
• Geneone Life Science
• Vaccitech

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Europe Air Ambulance Services Market Estimated to Experience a Hike in Growth by 2028: Grand View Research Inc.

 Europe Air Ambulance Services Market Growth & Trends

The Europe air ambulance services market size is expected to reach USD 9.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.2% from 2021 to 2028. The surge in the prevalence of chronic diseases, the rising geriatric population, and increasing healthcare expenditure are key factors for driving the market.

Increasing government funding and initiatives to support air ambulance services in Europe, is stimulating market growth. For instance, recently in April 2021, Norway and the EU had planned to launch an air ambulance with a permanent base in Troms. As part of RescEU, this aircraft will be used to transport patients with severe infectious ailments across the EEA and the entire EU. The aircraft will be integrated into the National Air Ambulance Services of Norway when not used in European assignments. Moreover, Ambulancezorg Nederland (AZN), the national sector institute for ambulance care, provides support to 25 Regional Ambulance Services (RAVs).

COVID-19 pandemic has significantly impacted the market. An upsurge in demand for helicopter emergency medical services from hospitals, health insurance firms, assistance companies, and independent end-users is witnessed amidst COVID-19. Moreover, rising investments in the healthcare domain due to COVID-19 will further boost the market growth. For instance, in September 2020, the Norwegian Air Ambulance Foundation received a 5-bladed Airbus H145 helicopter. The helicopter will help deliver comfort, simplicity, and connectivity and increase the useful load by 150 kg. It has also obtained certification from the European Union Aviation Safety Agency.

Request a free sample copy or view report summary: Europe Air Ambulance Services Market Report

Europe Air Ambulance Services Market Report Highlights

• In terms of type, the rotary-wing segment held the largest share in 2020, owing to the surge in demand for helicopter emergency medical services
• In terms of model, the community-based segment is anticipated to a witness considerable growth rate over the forecast period, due to rising partnerships between private players and community health organizations
• In Germany, the market is expected to witness the fastest growth over the forecast period owing to increasing healthcare expenditure

Access Press Release@ https://www.grandviewresearch.com/press-release/europe-air-ambulance-services-market-analysis

Europe Air Ambulance Services Market Segmentation

Grand View Research has segmented the Europe air ambulance services market on the basis of type, model, and country:

Europe Air Ambulance Services Type Outlook (Revenue, USD Million, 2016 - 2028)

• Rotary Wing
• Fixed Wing

Europe Air Ambulance Services Model Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital-based
• Community-based

Europe Air Ambulance Services Country Outlook (Revenue, USD Million, 2016 - 2028)

• UK.
• Germany
• France
• Italy
• Spain

List of Key Players of Europe Air Ambulance Services Market

• Aero Medical Ambulance Service
• Aero-Dienst GmbH
• Airlec Air Espace
• European Air Ambulance
• REVA, Inc.
• IAS Medical
• Medical Air Service
• Quick Air Jet Charter GmbH
• Babcock Scandinavian Air Ambulance
• Centreline AV Limited
• Airbus S.A.S.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Chile Ultrasound Devices Market Get Facts About Business Strategies 2021 to 2028: Grand View Research Inc.

 Chile Ultrasound Devices Market Growth & Trends

The Chile ultrasound devices market size is expected to reach USD 192.3 million by 2028. The market is expected to expand at a CAGR of 2.3% from 2021 to 2028. The increasing prevalence of lifestyle-associated diseases and technological advancements are some of the major market players. Cancer affects a considerable portion of the Chilean population, with prostate cancer ranking 1 amongst others, the adoption of ultrasound devices in the diagnosis of cancer is expected to boost the market growth. Additionally, manufacturers are using new strategies that allow them to use their resources to help develop new products and improve their supply chain. For instance, In March 2021, GE Healthcare announced the launch of Vscan Air, new wireless, hand-held ultrasound device, it is about the size of an iPhone and connects to a smartphone app to read the ultrasound images.

The Chilean government is committed to investment in health infrastructure, and in 2018 President unveiled Chile's 2018-2022 USD 10 billion hospital infrastructure plan. However, the health system in Chile is strained due to a lack of skilled medical staff. According to the ministry of foreign affairs, in 2016, there were 2.3 doctors per 1000 persons.

For medical devices and supplies, Chile is 95% reliant on imports. The medical device market in Chile is competitive, with numerous companies from around the world easily finding their way in. The rise in public hospital infrastructure will create an increased demand for ultrasound devices as the Chilean government will invest large sums in hospital construction in the future years.

Request a free sample copy or view report summary: Chile Ultrasound Devices Market Report

Chile Ultrasound Devices Market Report Highlights

• The diagnostic imaging ultrasound segment dominated the market and accounted for the largest revenue share of more than 60.0% in 2020, as it has a wide range of applications in obstetrics, radiography, and oncology
• The therapeutic ultrasound devices segment is expected to grow at a significant rate during the forecast period
• The market is expected to grow as ultrasound techniques such as HIFU and ESWL are being adopted for various therapeutic treatments
• The diagnostic imaging ultrasound device segment is predicted to be driven by rising demand for improved diagnostic devices such as miniaturized 2D and 3D/4D
• The cart/trolley based devices segment dominated the market and accounted for the largest revenue share of 55.0% in 2020
• To get a competitive advantage over competitors, leading market manufacturers are investing in Chile

Access Press Release@ https://www.grandviewresearch.com/press-release/chile-ultrasound-devices-market-analysis

Chile Ultrasound Devices Market Segmentation

Grand View Research has segmented the Chile ultrasound devices market based on product and portability:

Chile Ultrasound Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Therapeutic Ultrasound Devices
  • High-intensity Focused Ultrasound
  • Extracorporeal Shockwave Lithotripsy
• Diagnostic Imaging Ultrasound Devices
  • 2D
  • 3D/4D
  • Doppler

Chile Ultrasound Devices Portability Outlook (Revenue, USD Million, 2016 - 2028)

• Handheld Devices
• Cart/Trolley Based Devices

List of Key Players of Chile Ultrasound Devices Market

• Canon Medical Systems Corporation
• GE Healthcare
• Philips Healthcare
• Siemens Healthcare GmbH
• Hitachi Medical Corporation
• Samsung Medison
• Mindray Medical International Limited

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Hospital Bedsheet & Pillow Cover Market Outlook & Future Forecast Report Till 2028

 Hospital Bedsheet & Pillow Cover Market Growth & Trends

The global hospital bedsheet & pillow cover market size is expected to reach USD 8.1 billion by 2028, registering a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. Increasing number of surgeries performed and hospitalizations, is the key factor driving the market growth. Moreover, the rising prevalence of nosocomial infections, such as bloodstream, urinary tract, surgical site infections, and pneumonia, will boost the market growth over the forecast period.

For instance, the Centers for Disease Control (CDC) predicted that in American hospitals HAIs account for around 1.7 million infections and 99,000 related deaths every year. Of these infections Urinary Tract Infections (UTIs) account for 32%, Surgical Site Infections (SSIs) hold 22%, pneumonia (lung infections) holds 15%, and bloodstream infections account for 14%. Thus, with increasing cases of nosocomial infections, the demand for preventive services will increase, thereby, boosting the demand for hospital pillow covers and bedsheets.

In addition, the number of hospital admissions is also increasing at an exponential rate. For instance, according to the American Hospital Association, total admissions in all U.S. hospitals were 36,241,815. The rising number of admissions will, in turn, augment the product demand, thereby propelling the market growth in the U.S. The rising demand for maintenance and hygiene in healthcare institutes is also one of the key factors stimulating the growth of the market. A lot of hospitals and healthcare centers are considerably focusing on upgrading the quality of infrastructure and hygiene, efficacy, and maintenance of operational systems.

Request a free sample copy or view report summary: Hospital Bedsheet & Pillow Cover Market Report

Hospital Bedsheet & Pillow Cover Market Report Highlights

• In terms of type, the bedsheet segment held the largest market share in 2020 and will expand further at a steady CAGR from 2021 to 2028
• Rising demand for bedsheets in hospitals across the globe owing to the increasing COVID-19 cases is driving the segment
• In terms of product, the reusable segment held the largest market share in 2020 and is expected to witness a considerable growth rate over the forecast period
• Asia Pacific is expected to be the largest regional market by 2028 owing to the rising number of surgeries performed and the presence of many local key players

Access Press Release@ https://www.grandviewresearch.com/press-release/global-hospital-bedsheet-pillow-cover-market

Hospital Bedsheet & Pillow Cover Market Segmentation

Grand View Research has segmented the global hospital bedsheet & pillow cover market on the basis of type, product, and region:

Hospital Bedsheet & Pillow Cover Type Outlook (Revenue, USD Million, 2016 - 2028)

• Bedsheet
• Pillow Cover

Hospital Bedsheet & Pillow Cover Product Outlook (Revenue, USD Million, 2016 - 2028)

• Reusable
• Disposable

Hospital Bedsheet & Pillow Cover Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Hospital Bedsheet & Pillow Cover Market

• Unitex Textile Rental Services, Inc.
• Emes Textiles Pvt. Ltd.
• Angelica Corp.
• Elizabethtown Laundry Company
• Healthcare Services Group, Inc.
• ImageFIRST
• Tetsudo Linen Service Co., Ltd.
• Celtic Linen
• V-linen Pvt. Ltd.
• Raenco Mills

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

qPCR Instruments Market Top Players, Segments, Cost Structure, Demand, Sales | 2028 Forecast

 qPCR Instruments Market Growth & Trends

The global qPCR instruments market size is expected to reach USD 1.39 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.4% from 2021 to 2028. The market is driven by the introduction of novel advanced products and an increase in demand for highly efficient diagnostic equipment.

The demand for qPCR instruments and consumables is being driven by the spike in the incidence of SARS-CoV-2 infections globally. The rise in the incidence is expected to add to the number of preventive screenings. This can be attributed to the fact that nations cannot determine the number of COVID-19 patients without screening them.

The miniaturization of three basic molecular assays is expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to improve the availability of POC molecular diagnostic tests to yield quick and effective test results. For instance, the Mic qPCR system by Biomolecular Systems weighs only 2 kilograms, making the device highly portable and easy to handle.

Newly launched products such as QuantStudio 5 Dx Real-Time PCR System provide consumers with improved workflows and high-volume testing to provide faster results. Cost-effectiveness and software that are simplified give it additional advantages. Furthermore, the approval of the instrument in over 50 countries can help strengthen the market growth. The instrument is also equipped with measures for research companion diagnostics, giving it a competitive edge.

The market has a high threat of external substitutes owing to the presence of digital PCR instruments that are highly advanced and more accurate. The strong threat of internal substitution can be attributed to the presence of numerous products available in the market. However, the higher price of these instruments is anticipated to reduce the overall threat, keeping it at a moderate level.

COVID-19 has increased opportunities for diagnostic devices. However, advanced PCR technologies, such as dPCR, are preferred more in developed economies as they can help reduce false-positive rates. The research on developing efficient qPCR instruments can reduce the threat of substitution of devices and improve market growth.

Over recent years, PCR has witnessed technological advancements in terms of sensitivity, accuracy, efficiency, and cost-effectiveness. Key players are introducing novel technologies to maintain a competitive edge.

Request a free sample copy or view report summary: qPCR Instruments Market Report

qPCR Instruments Market Report Highlights

• By instrument, the GeneXpert segment is expected to exhibit the fastest CAGR from 2021 to 2028
• Asia Pacific is expected to witness the fastest growth over the forecast period due to the increasing number of investments aimed at improving diagnostic infrastructure and the growing prevalence of infectious diseases
• Unmet needs in the market are high. For instance, the lack of affordable qPCR instruments is keeping the market from reaching its full potential
• Newly launched products such as QuantStudio 5 Dx Real-Time PCR System provide consumers with improved workflows and high-volume testing to provide faster results. Cost-effectiveness and software that are simplified give it additional advantages
• North America captured the largest revenue share in 2020 and is expected to maintain its lead over the forecast period. Improving regulatory support and increasing launches of novel products are anticipated to fuel the market growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-qpcr-instruments-market

qPCR Instruments Market Segmentation

Grand View Research has segmented the global qPCR instruments market based on instrument and region:

qPCR Instruments Outlook (Revenue, USD Million, 2017 - 2028)

• 7500
• QuantStudioDx Real-Time PCR System
• QuantStudio 5 Real-Time PCR System
• ViiA 7 Dx
• StepOne/ StepOne Plus
• LightCycler 2.0/ 96/ 480/ 1536
• Cobas 4800
• CFX96
• SmartCycler
• GeneXpert
• Rotor-Gene Q 5Plex HRM System
• Rotor-Gene Q
• BioFire FilmArray Systems
• BMS Mic System

qPCR Instruments Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • UAE

Key Players of qPCR Instruments Market

• Thermo Fisher Scientific, Inc.
• Hoffmann-La Roche Ltd.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Qiagen
• Agilent Technologies, Inc.
• Abbott
• bioMérieux SA
• Quantabio
• Azure Biosystems, Inc.
• Bio Molecular Systems

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Restricted Access Barrier System Market Size Is Expected To Reach USD 249.4 Million by 2028

 U.S. Restricted Access Barrier System Market Growth & Trends

The U.S. restricted access barrier system market size is expected to reach USD 249.4 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.7% from 2020 to 2028. The market is primarily driven by the growth of the biotechnology industry in the U.S. due to technological advancements, an increasing number of small-scale biopharma companies, and rising investments in research.

Technological breakthroughs in biopharmaceutical and biotechnology manufacturing are expected to surge the market growth over the forecast period. The demand for modular equipment having the ability to reduce the time required for drug production and minimize the overall production cost is anticipated to provide a major boost to the market growth in the U.S.

The COVID-19 pandemic has reinstated the significance of collaborations; many life science companies are partnering among themselves to enhance R&D in the field of biotechnology. The pandemic has accelerated the need for sustainable development, energy conservation, and green pharmaceutical manufacturing, thereby influencing product development in the restricted access barrier systems (RABS) market.

A growing trend of contract development and manufacturing organization (CDMO) for aseptic manufacturing is expected to augment the demand for RABS. Contract manufacturers such as Aenova Group, DPT Laboratories, and Recipharm AB are focusing on new contracts in the U.S., in turn, positively impacting the market growth.

Request a free sample copy or view report summary: U.S. Restricted Access Barrier System Market Report

U.S. Restricted Access Barrier System Market Report Highlights

• The pharmaceutical application segment accounted for the largest share of 64.5% in 2020 owing to the growing pharmaceutical industry in the U.S., coupled with advantages such as a faster changeover process and easy handling
• The medical application segment is expected to expand at a CAGR of 3.9% from 2020 to 2028. This is attributed to the growing penetration of RABS in this segment owing to its ability to provide septic safety in the critical zone and flexibility for interventions
• The U.S. government is aiming to reduce the reliance on drugs manufactured outside the U.S. by encouraging pharmaceutical companies to set up manufacturing facilities in the U.S., in turn, augmenting the demand for RABS
• In February 2021, Comecer spA partnered with Illuminate Manufacturing Intelligence, a division of ATS (ATA.TO), to develop a production solution integrating its containment equipment portfolio in line with Industry 4.0

Access Press Release@ https://www.grandviewresearch.com/press-release/us-restricted-access-barrier-system-market-analysis

U.S. Restricted Access Barrier System Market Segmentation

Grand View Research has segmented the U.S. restricted access barrier system market on the basis of application:

U.S. Restricted Access Barrier System Application Outlook (Revenue, USD Million, 2017 - 2028)

• Pharmaceutical
• Chemical Manufacturing
• Medical
• Others

List of Key Players of the U.S. Restricted Access Barrier System Market

• M.A. Industria Macchine Automatiche S.P.A.
• Germfree Laboratories, Inc.
• Extract Technology
• AZBIL TELSTAR, S.L.U.
• Syntegon Technologies GmbH
• Isolation Systems Inc.
• Shanghai Tofflon Science and Technology Co., Ltd.
• Ortner Reinraumtechnik GmbH
• COMECER S.p.A.
• SKAN AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Aquaculture Vaccines Market is Anticipated to Upgrade USD 605.4 Million Revenue By 2028: Grand View Research Inc.

 Aquaculture Vaccines Market Growth & Trends

The global aquaculture vaccines market size is expected to reach USD 605.4 million by 2028, according to a new report by Grand View Research. It is expected to expand at a CAGR of 8.4% from 2021 to 2028. The advent of vaccines for fish has significantly reduced the dependency on antimicrobial agents. Vaccination programs help in protecting the animal health and livelihoods of those who work with livestock as well as aid in ensuring food security. The development of some aquaculture sectors, such as the salmon industry in Norway, wherein fish farmers in the country moved from using antibiotics to vaccines by 1994, demonstrates the potential of vaccines in reducing the dependence on veterinary medicines.

Similar to other markets, the market for aquaculture vaccines has also been significantly affected. Some of the major impacts of COVID-19 on the market include supply chain disruptions, a decline in sales, low demand, growing awareness of animal to human disease transmission risks, and operational hurdles due to changing policies and restrictions.

The growing demand for aquatic animal-derived food products, such as oil, caviar, protein powders, and meat, is encouraging farmers to use vaccinations for aquaculture to gain higher profitability. Due to the rising urbanization, consumers are becoming more aware of the nutritious value of animal protein. The demand for healthy, sustainable, and high-quality meat products that have fewer or no drugs is also increasing rapidly. Thus, the need for healthy breeding of aquatic animals is increasing, which is expected to fuel the demand for aquaculture vaccines, thereby boosting the market growth.

The market for aquaculture vaccines is fairly competitive. The most notable participants in the market are Zoetis; Merck & Co., Inc.; and Elanco, along with other manufacturers of aquaculture vaccines. These players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, in July 2020, Zoetis acquired Fish Vet Group from Benchmark Holdings, PLC. This added to the company’s Pharmaq business, which is involved in fish vaccines and services.

Request a free sample copy or view report summary: Aquaculture Vaccines Market Report

Aquaculture Vaccines Market Report Highlights

• Based on product, the inactivated vaccines segment held the largest share in 2020 owing to its high acceptance globally
• By route of administration, the injected segment held the largest market share in 2020 owing to its easy availability
• The bacterial application segment held the largest revenue share in 2020 owing to the high prevalence of bacterial diseases in aquatic species
• In 2020, Europe held the largest revenue share owing to the increasing adoption of aquaculture vaccines, especially in countries such as Norway and the U.K.
• North America held the second-largest revenue share in 2020. The key driver in this regional market is the presence of major market players, especially in the U.S.
• Asia Pacific is expected to witness lucrative growth over the forecast period owing to the rise in aquaculture production and favorable government initiatives, especially in developing countries 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-aquaculture-vaccines-market

Aquaculture Vaccines Market Segmentation

Grand View Research has segmented the global aquaculture vaccines market report on the basis of product, route of administration, application, and region:

Aquaculture Vaccines Product Outlook (Revenue, USD Million, 2016 - 2028)

• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

Aquaculture Vaccines Route Of Administration Outlook (Revenue, USD Million, 2016 - 2028)

• Oral
• Injected
• Immersion & Spray

Aquaculture Vaccines Application Outlook (Revenue, USD Million, 2016 - 2028)

• Bacterial
• Viral
• Parasitic

Aquaculture Vaccines Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Ireland
  • Eastern Europe
    • Croatia
    • Czech Republic
    • Hungary
    • Poland
    • Russia
    • Romania
    • Bulgaria
  • Asia Pacific
    • Japan
    • South Korea
    • Taiwan
    • Indonesia
    • Malaysia
    • Singapore
    • Thailand
    • Philippines
    • Vietnam
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Colombia
    • Peru
    • Ecuador
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Israel
    • Egypt

List of Key Players of Aquaculture Vaccines Market

• Zoetis
• Phibro Animal Health Corporation
• Elanco
• Merck & Co., Inc.
• KBNP
• CAVAC
• Kyoto Biken Laboratories, Inc.
• Nisseiken Co., Ltd.
• Vaxxinova International BV
• HIPRA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pressure Sensor Market- Advancements In MEMS Technology And Its Rapid Adoption In Connected Devices

 

Know More- https://www.grandviewresearch.com/industry-analysis/pressure-sensors-industry

A pressure sensor is an electronic device that regulates, detects, and monitors the pressure in liquids or gases and converts it into an electrical signal. Pressure sensors are witnessing significant growth owing to their increasing use across industries for applications such as alarm systems, water purifiers, medical breathing appliances, refrigeration systems, and off-road constructions. The pressure sensors used in medical breathing appliances measure the flow of oxygen and oxygen levels being delivered to the patient. The increasing demand for medical breathing appliances owing to the COVID-19 pandemic is driving the demand for pressure sensors in recent days.

Endometrial Ablation Market to Surpass USD 5.4 Billion by 2028: Grand View Research Inc.

 Endometrial Ablation Market Growth & Trends

The global endometrial ablation market size is expected to reach USD 5.4 billion by 2028, registering a CAGR of 5.2% over the forecast period, according to a new report by Grand View Research, Inc. Endometrial ablation is a highly efficient procedure that helps in removing or destroying the uterine endometrial lining in women who experience heavy menstrual bleeding using specific devices. The growing prevalence of gynecological disorders and growing public awareness about endometrial ablation are key contributing factors expected to propel the product demand. According to the International Federation of Gynecology and Obstetrics (FIGO), globally, the prevalence of Abnormal Uterine Bleeding (AUB) among reproductive-aged women is estimated to be between 3 to 30%

For women suffering from painful, heavy periods, endometrial ablation for endometriosis offers an alternative to chronic medication and hysterectomy treatments. Improved features and a higher demand for these procedures and devices due to the advantages over surgical methods, such as minimally invasive nature, low-risk profile, and easy operation, will support market growth. Many global, as well as local key players, are opting for different strategies. For instance, In March 2020, Mara Water Vapor Ablation System from AEGEA Medical has been approved by the U.S. FDA. Mara is the endometrial ablation procedure that uses natural water vapor to safely cure heavy menstrual bleeding without the need for general anesthesia.

Endometrial ablation procedures have proven effective in about 10% of people to no longer have menstrual periods. Bleeding is effectively decreased in another 70% of cases. However, there are certain side effects associated with the procedure, which include infection, tearing of the uterine wall or bowel, which may hamper the market growth. As a result of the COVID-19 pandemic, the healthcare system had to deal with a lot of difficulties, all outpatient procedures were limited or stopped to lower the impact of virus outbreaks. This also had a negative impact on the overall market growth.

Request a free sample copy or view report summary: Endometrial Ablation Market Report

Endometrial Ablation Market Report Highlights

• The radiofrequency ablation device segment dominated the market with a revenue share of 26.3% in 2020
• The segment is expected to continue its dominance during the forecast period
• The thermal balloon segment is expected to grow at a significant rate during the forecast period
• The hospital end-use segment held the largest revenue share of more than 55% in 2020
• The high growth is credited to the availability of technologically improved medical devices in hospitals
• The Ambulatory Surgery Center (ASC) end-use segment is expected to exhibit the fastest CAGR during the forecast period
• ASCs have shorter stay duration, little or no danger of Hospital-Acquired Infections (HAIs), and are more convenient than other healthcare facilities

Access Press Release@ https://www.grandviewresearch.com/press-release/global-endometrial-ablation-market

Endometrial Ablation Market Segmentation

Grand View Research has segmented the global endometrial ablation market based on type, end-use, and region:

Endometrial Ablation Type Outlook (Revenue, USD Million, 2016 - 2028)

• Devices
  • Cryoablation
  • Radiofrequency Ablation
  • Hydrothermal Ablation
  • Thermal Balloon
  • Microwave Energy
• Procedures

Endometrial Ablation End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital
• Clinic
• Ambulatory Surgery Center

Endometrial Ablation Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Sweden
  • Russia
• Asia Pacific
  • Japan
  • India
  • China
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East and Africa
  • Saudi Arabia
  • Turkey
  • UAE
  • Qatar
  • South Africa

List of Key Players of Endometrial Ablation Market

• Medtronic
• CooperSurgical Inc.
• Boston Scientific Corp.
• Ethicon, Inc. (Johnson & Johnson)
• Olympus Corp.
• Richard Wolf GmbH
• AngioDynamics
• Hologic, Inc.
• Minerva Surgical, Inc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Canada Varicose Vein Treatment Devices Market Size Is Predicted To Reach A Valuation Of USD 77 Million By 2028: Grand View Research Inc.

 Canada Varicose Vein Treatment Devices Market Growth & Trends

The Canada varicose vein treatment devices market size is expected to reach USD 77 million by 2028, registering a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. High prevalence of varicose veins due to risk factors, such as pregnancy, sedentary lifestyle, obesity, and physical activities like standing for longer durations is expected to drive the market growth.

Hypertension is one of the main risk factors for varicose veins. In Canada, conditions like hypertension are rising, with 22% of adults having hypertension issues. Furthermore, the aging population is increasing significantly in Canada. With a rise in the geriatric population, cases of varicose veins are anticipated to increase as they are at a higher risk. Overall, 26% of adults in Canada have varicose veins as per the Canadian Society of Vascular Surgery, signifying high disease prevalence, thereby favoring the market growth.

However, the COVID-19 pandemic has negatively impacted the market as all non-urgent elective procedures, including varicose veins treatment surgeries, was postponed. Manufacturers operating in the market witnessed a decline in their revenues. The public healthcare system of Canada emphasizes more on conservative management of varicose veins rather than surgical procedures.

Request a free sample copy or view report summary: Canada Varicose Vein Treatment Devices Market Report

Canada Varicose Vein Treatment Devices Market Report Highlights

• Canada has been witnessing a surge in the number of varicose veins cases in recent years
• According to the Canadian Society of Vascular Surgery, around 50% of people with varicose veins are aged 50 years and above
• Overall, 3.7 million people in Canada suffer from varicose veins and women are at a higher risk than men
• The sclerotherapy type segment accounted for the largest market share in 2020
• The growth is credited to the high adoption of this treatment due to the advantages, such as no need for anesthesia, no scarring, simple follow-up treatments, and no need for hospital admission
• The endovenous ablation segment is anticipated to witness the fastest CAGR over the forecast period as this treatment is preferred over conventional procedures, such as surgical stripping and ligation
• The hospitals end-use segment held a major share of the market in 2020 owing to the well-established healthcare infrastructure in Canada
• Product development, supply agreements with hospitals & clinics, and acquisitions are some of the strategic initiatives being undertaken by key market players to gain a higher market share

Access Press Release@ https://www.grandviewresearch.com/press-release/canada-varicose-vein-treatment-devices-market-analysis

Canada Varicose Vein Treatment Devices Market Segmentation

Grand View Research has segmented the Canada varicose vein treatment devices market on the basis of type and end use:

Canada Varicose Vein Treatment Devices Type Outlook (Revenue, USD Million, 2016 - 2028)

• Endovenous Ablation
  • Endovenous Laser Ablation (EVLA)
  • Fetal Radiofrequency Ablation (RFA)
• Sclerotherapy
• Surgical Ligation & Stripping

Canada Varicose Vein Treatment Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Ambulatory Care Unit
• Vein Clinics
• Hospitals

List of Key Players of Canada Varicose Vein Treatment Devices Market

• Angiodynamics
• Medtronic
• Teleflex, Inc.
• Sciton, Inc.
• Biolitec AG
• Dornier Medtech
• Merit Medical Systems
• Alma Lasers
• Boston Scientific Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.